Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Xu (Beijing, China), X. Jia (Shanghai, China), J. Xu (Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China, China). CARD9S12N allele expression imbalance favors development of allergic bronchopulmonary aspergillosis. 917

Member's Comments

No comment yet.

Related content which might interest you: Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2009 - Airways remodelling Year: 2009 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003 Oct 01;22(4):592-595 Year: 2003 Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Treating allergic bronchopulmonary aspergillosis: the way forward Source: Eur Respir J 2016; 47: 385-387 Year: 2016 Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy Source: Eur Respir J 2003; 22: Suppl. 45, 237s Year: 2003 Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003; 21: 582-588 Year: 2003 Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2016; 47: 177-185 Year: 2016 Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2008; 31: 36-42 Year: 2008 Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA) Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Allergic bronchopulmonary aspergillosis and other fungal diseases Source: Eur Respir Mon 2011; 52: 97-114 Year: 2011 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017